Used in research for developing antiviral therapies targeting Ebola virus (EBOV) and Marburg virus (MARV). Shows inhibitory activity against viral replication in cell-based assays, making it a candidate for early-stage drug discovery in treating filovirus infections. Studied for its potential to block key viral proteins involved in infection, aiding the design of broad-spectrum antihemorrhagic fever virus agents.